Thursday, June 30, 2016

BRIEF-Galmed Pharmaceuticals says enters research collaboration agreement

* Has right to enter into exclusive negotiations with Yeda

to complete license agreement to commercialize diagnostic,

prognostic tool for Aramchol

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)